ImmunoPrecise Antibodies (IPA) News Today

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

$1.24

-0.03 (-2.36%)

(As of 04/18/2024 ET)

Source

Source	Headline
	InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications finance.yahoo.com - March 28 at 10:12 AM
	InterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications businesswire.com - March 28 at 7:02 AM
	IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments businesswire.com - March 20 at 7:02 AM
	ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2024 Earnings Call Transcript msn.com - March 15 at 4:00 PM
	IPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024 investorplace.com - March 14 at 1:03 PM
	IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology finance.yahoo.com - March 7 at 9:28 AM
	IPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology businesswire.com - March 7 at 7:02 AM
	IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 finance.yahoo.com - March 4 at 10:48 AM
	ImmunoPrecise Antibodies (NASDAQ:IPA) Shares Down 2.3% marketbeat.com - February 10 at 2:55 AM
	Buy Rating on ImmunoPrecise Antibodies Reflects Strong Revenue Growth and Cost Management Success markets.businessinsider.com - December 16 at 12:58 PM
	IPA Announces Closing of $1.265 Million Public Offering of Common Shares finance.yahoo.com - December 8 at 6:18 PM
	Why ImmunoPrecise Antibodies (IPA) Stock Is Down 20% Today benzinga.com - December 6 at 2:39 PM
	Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today? investorplace.com - December 6 at 10:01 AM
	IPA Announces Pricing of $1.1 Million Public Offering of Common Shares finance.yahoo.com - December 6 at 9:39 AM
	After-hours movers: SentinelOne up on earnings, MongoDB sees 'sell the news' reaction investing.com - December 5 at 6:19 PM
	IPA Announces Proposed Public Offering of Common Shares finance.yahoo.com - December 5 at 6:19 PM
	ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call businesswire.com - November 27 at 8:06 AM
	ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery finance.yahoo.com - November 22 at 10:00 AM
	ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery benzinga.com - November 20 at 9:26 AM
	IPA's Subsidiary, BioStrand, Provides an Update on LENSai(TM) stockhouse.com - October 25 at 10:23 AM
	IPA's Subsidiary, BioStrand, Provides an Update on LENSai™ benzinga.com - October 25 at 10:23 AM
	IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™ financialpost.com - October 25 at 8:12 AM
	Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data finance.yahoo.com - October 20 at 1:28 PM
	How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research finance.yahoo.com - October 20 at 8:28 AM
	ImmunoPrecise Antibodies Announces CFO Transition finance.yahoo.com - September 19 at 9:06 AM
	HC Wainwright & Co. Reiterates ImmunoPrecise Antibodies (IPA) Buy Recommendation nasdaq.com - September 18 at 7:19 PM
	ImmunoPrecise Antibodies (IPA) Receives a Buy from H.C. Wainwright markets.businessinsider.com - September 18 at 9:18 AM
	ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call Transcript finance.yahoo.com - September 17 at 1:28 PM
	IPA Announces Board Refreshment finance.yahoo.com - September 5 at 8:26 AM
	IPA Responds to 13D Filing finance.yahoo.com - August 9 at 11:07 AM
	ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023 finance.yahoo.com - July 7 at 10:02 AM
	ImmunoPrecise Antibodies's Earnings Outlook msn.com - July 6 at 11:40 AM
	IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023. finance.yahoo.com - June 29 at 12:42 PM
	IPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems Biology finance.yahoo.com - May 30 at 8:55 AM
	IPA to Present at Jefferies Healthcare Conference 2023 finance.yahoo.com - May 17 at 9:13 AM
	TheStreetReports: Disruptive Technology Stocks in Focus – KAVL, SONM, PBTS, IPA benzinga.com - April 18 at 7:34 PM
	ImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with Astellas finance.yahoo.com - March 30 at 9:16 AM
	European Patent Office to Grant BioKey's Patent Application for Foundational HYFT® Technology stockhouse.com - March 29 at 12:42 PM
	European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology finance.yahoo.com - March 27 at 10:20 AM
	ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival Rates finance.yahoo.com - March 23 at 10:28 AM
	ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio finance.yahoo.com - March 15 at 8:20 AM
	IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023 finance.yahoo.com - March 7 at 4:21 PM
	Analysts Are Bullish on Top Healthcare Stocks: Rigel (RIGL), ImmunoPrecise Antibodies (IPA) markets.businessinsider.com - December 22 at 12:37 PM
	IPA’s Subsidiary BioStrand Completes Integration of 20 Million Proprietary Structural HYFTs™ and Accelerates in Silico Drug Discovery Developments finance.yahoo.com - December 8 at 2:26 PM
	IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022 finance.yahoo.com - December 5 at 9:15 AM
	ImmunoPrecise Antibodies (NASDAQ:IPA) Receives New Coverage from Analysts at HC Wainwright marketbeat.com - December 2 at 7:48 AM
	IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies finance.yahoo.com - November 30 at 8:09 AM
	ImmunoPrecise Antibodies to delist from TSXV seekingalpha.com - November 22 at 4:01 PM
	ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting from TSX Venture Exchange finance.yahoo.com - November 22 at 4:01 PM
	ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Sees Large Decline in Short Interest marketbeat.com - November 16 at 4:21 PM

Get ImmunoPrecise Antibodies News Delivered to You Automatically

AI “wealth window” is closing soon! (Ad)

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

IPA Media Mentions By Week

IPA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IPA
News Sentiment
▼
0.00

0.53
▲
Average
Medical
News Sentiment

IPA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IPA Articles
This Week
▼
0

0
▲
IPA Articles
Average Week

Get ImmunoPrecise Antibodies News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:IPA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ImmunoPrecise Antibodies (IPA) News Today

IPA Media Mentions By Week

IPA Media Sentiment

IPA News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info